1. Borden, W.B., Redberg, R.F., Mushlin, A.I., Dai, D., Kaltenbach, L.A. & Spertus, J.A. (2011) Patterns and intensity of medical therapy in patients undergoing percutaneous coronary intervention. JAMA, 305, 1882-1889.
2. Bradley, S.M., Bohn, C.M., Malenka, D.J., Graham, M.M., Bryson, C.L., McCabe, J.M., Curtis, J.P., Lambert-Kerzner, A. & Maynard, C. (2015) Temporal trends in percutaneous coronary intervention appropriateness: insights from the clinical outcomes assessment program. Circulation, 132, 20-26.
3. Bruggmann, C., Iglesias, J.F., Gex-Fabry, M., Fesselet, R., Vogt, P., Sadeghipour, F. & Voirol, P. (2020) Long-term quality of prescription for ST-segment elevation myocardial infarction (STEMI) patients: a real world 1-year follow-up study. Am. J. Cardiovasc. Drugs, 20, 105-115.
4. Byeon, H.J., Yang, Y.M. & Choi, E.J. (2016) Optimal medical therapy for secondary prevention after an acute coronary syndrome: 18-month follow-up results at a tertiary teaching hospital in South Korea. Ther. Clin. Risk Manag., 12, 167-175.
5. Charlton, J., Ravindrarajah, R., Hamada, S., Jackson, S.H. & Gulliford, M.C. (2018) Trajectory of total cholesterol in the last years of life over age 80 years: cohort study of 99,758 participants. J. Gerontol. A Biol. Sci. Med. Sci., 73, 1083-1089.